Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro
- 30 August 2002
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 53 (2) , 101-108
- https://doi.org/10.1002/pros.10129
Abstract
BACKGROUND: Dispersed prostatic neuroendocrine cells are involved in growth regulation of the prostate and are considered to play a role in the pathogenesis of prostate carcinoma and benign prostatic hyperplasia (BPH). They are meant either to be derived from the neural crest during embryogenesis or by direct differentiation of the cells from locally present precursor cells.METHODS: An in vitro model was developed for human prostatic epithelial and neuroendocrine cell differentiation. Minced explants from radical prostatectomies were seeded on collagen I–coated plates.RESULTS: The majority of outgrowing cells were basal cells, positive for cytokeratin markers K 5/14 and CD 44, as determined by confocal laser scanning microscopy. A small fraction of interdispersed single cells expressing c‐kit, which is found on pluripotent precursors, was identified by immunofluorescence. From these basal cells, in vitro differentiation of cells with neuroendocrine morphology could be achieved within 3 days. These were at rest, i.e., non‐bromodeoxyuridine incorporating cells and characteristically coexpressed K 5/14, K 18, and the neuroendocrine marker chromogranin A. Luminal cells staining for K 8 or 18 were not observed.CONCLUSION: Neuroendocrine differentiation of adult prostatic cells was achieved in vitro, favoring the hypothesis that neuroendocrine cells are derived from peripheral precursor cells. The acceleration of this differentiation pathway may be the reason for the increased presence of neuroendocrine cells in areas of epithelial hyperplasia in BPH. Prostate 53: 101–108, 2002.Keywords
This publication has 42 references indexed in Scilit:
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001
- Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablationHepatology, 2000
- TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVOJournal of Urology, 1999
- HORMONE-REFRACTORY PROSTATE CANCER CELLS EXPRESS FUNCTIONAL FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR)Journal of Urology, 1999
- Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostateThe Prostate, 1998
- Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-IIEuropean Journal Of Cancer, 1997
- Sequence Analysis of Two Genomic Regions Containing the KIT and the FMS Receptor Tyrosine Kinase GenesGenomics, 1997
- Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cellsJournal of Molecular Endocrinology, 1996
- Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic CarcinomaJournal of Urology, 1996
- Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transientsEndocrinology, 1994